Search

everythinglearnresearchcommunity

for

Search:↓

The authors updated the criteria for diagnosing frontal fibrosing alopecia, making it easier to diagnose without a biopsy.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

COVID-19 can cause significant hair loss.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

FFA's causes may include environmental triggers and genetic factors.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Fibrosing alopecia starts earlier in Latin American men and often looks like common male pattern baldness.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.

Trichoscopy is a useful tool for diagnosing and managing hair and scalp conditions, often better than traditional methods.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

Trichoscopy helps diagnose hairline recession causes in Egyptian women, with androgenetic alopecia being the most common.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Stress can stop hair growth in mice, and treatments can reverse this effect.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.